A carregar...
MYCN sensitizes neuroblastoma to the MDM2-p53 antagonists Nutlin-3 and MI-63
MYCN amplification is a major biomarker of poor prognosis, occurring in 25-30% of neuroblastomas. MYCN plays contradictory roles in promoting cell growth and sensitizing cells to apoptosis. We have recently shown that p53 is a direct transcriptional target of MYCN in neuroblastoma and that p53-media...
Na minha lista:
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3191119/ https://ncbi.nlm.nih.gov/pubmed/21725357 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/onc.2011.270 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|